NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy

Annals of Surgical Oncology

Volumn 19, Issue 8, 2012, Pages 2763-2772

  Liang, Zhe Long ^a   Kang, Kyeongah ^b   Yoon, Sukjoon ^b   Huang, Song Mei ^a   Lim, Jae Sung ^a   Kim, Jin Man ^a   Lim, Jong Seok ^b   Lee, Hyo Jin ^a  

^a Chungnam National University   (South Korea)

^b Sookmyung Women's University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; N MYC DOWNSTREAM REGULATED GENE 2; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN;

AGED; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER PROGNOSIS; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CLEAR CELL CARCINOMA; DISEASE SPECIFIC SURVIVAL; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; HAZARD RATIO; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OVERALL SURVIVAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; SIGNAL TRANSDUCTION; WOUND HEALING;

AGED; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; WOUND HEALING;

EID: 84865010143     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2204-3     Document Type: Article

References (35)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin. 55 74 108 15761078 10.3322/canjclin.55.2.74
2. A Zisman AJ Pantuck J Wieder, et al. 2002 Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma J Clin Oncol. 20 4559 4566 12454113 10.1200/JCO.2002.05.111
3. RJ Motzer TE Hutson P Tomczak, et al. 2009 Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma J Clin Oncol. 27 3584 3590 19487381 10.1200/JCO.2008.20. 1293 1:CAS:528:DC%2BD1MXhtVOnu7nI
4. A Zisman AJ Pantuck F Dorey, et al. 2001 Improved prognostication of renal cell carcinoma using an integrated staging system J Clin Oncol. 19 1649 1657 11250993 1:STN:280:DC%2BD3M3gsl2gtA%3D%3D
5. JJ Patard HL Kim JS Lam, et al. 2004 Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study J Clin Oncol. 22 3316 3322 15310775 10.1200/JCO.2004.09.104
6. I Frank ML Blute JC Cheville CM Lohse AL Weaver H Zincke 2002 An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score J Urol. 168 2395 2400 12441925 10.1016/S0022-5347(05)64153-5
7. T Klatte DB Seligson JT Leppert, et al. 2008 The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma J Urol. 179 61 66 17997430 10.1016/j.juro.2007.08.148
8. JS Lam T Klatte HL Kim, et al. 2008 Prognostic factors and selection for clinical studies of patients with kidney cancer Crit Rev Oncol Hematol. 65 235 262 17931881 10.1016/j.critrevonc.2007.08.003
9. RH Zhou K Kokame Y Tsukamoto C Yutani H Kato T Miyata 2001 Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart Genomics. 73 86 97 11352569 10.1006/geno.2000.6496 1:CAS:528:DC%2BD3MXisVyku78%3D
10. X Qu Y Zhai H Wei, et al. 2002 Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family Mol Cell Biochem. 229 35 44 11936845 10.1023/A:1017934810825 1:CAS:528: DC%2BD38XitFCls7w%3D
11. N Liu L Wang X Li, et al. 2008 N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis Nucleic Acids Res. 36 5335 5349 18689861 10.1093/nar/gkn504 1:CAS:528:DC%2BD1cXhtFWhsLzM
12. J Ma H Jin H Wang, et al. 2008 Expression of NDRG2 in clear cell renal cell carcinoma Biol Pharm Bull. 31 1316 1320 18591767 10.1248/bpb.31.1316 1:CAS:528:DC%2BD1cXhtFKms77E
13. EA Lusis MA Watson MR Chicoine, et al. 2005 Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma Cancer Res. 65 7121 7126 16103061 10.1158/0008-5472.CAN-05-0043 1:CAS:528:DC%2BD2MXns1WrtLc%3D
14. HS Phillips S Kharbanda R Chen, et al. 2006 Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis Cancer Cell. 9 157 173 16530701 10.1016/j.ccr.2006.02.019 1:CAS:528:DC%2BD28XivFWjtL4%3D
15. JJ Ma CG Liao X Jiang HD Zhao LB Yao TY Bao 2010 NDRG2 suppresses the proliferation of clear cell renal cell carcinoma cell A-498 J Exp Clin Cancer Res. 29 103 109 20673333 10.1186/1756-9966-29-103
16. SC Choi KD Kim JT Kim, et al. 2008 Expression of human NDRG2 by myeloid dendritic cells inhibits down-regulation of activated leukocyte cell adhesion molecule (ALCAM) and contributes to maintenance of T cell stimulatory activity J Leukoc Biol. 83 89 98 17911180 10.1189/jlb.0507300 1:CAS:528: DC%2BD1cXks1Srtg%3D%3D
17. YJ Kim SY Yoon JT Kim, et al. 2009 NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma Carcinogenesis. 30 598 605 19237607 10.1093/carcin/bgp047 1:CAS:528: DC%2BD1MXktFSrtLk%3D
18. SC Choi SR Yoon YP Park, et al. 2007 Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death Exp Mol Med. 39 705 714 18160841 1:CAS:528:DC%2BD1cXmtVOktQ%3D%3D
19. H Shi N Li S Li, et al. 2010 Expression of NDRG2 in esophageal squamous cell carcinoma Cancer Sci. 101 1292 1299 20331630 10.1111/j.1349-7006.2010. 01529.x 1:CAS:528:DC%2BC3cXmsF2qu7w%3D
20. A Mordalska J Latek T Ferenc, et al. 2010 Evaluation of NDRG2 gene expression in primary papillary thyroid carcinoma and in metastases of this neoplasm to regional lymph nodes Thyroid Res. 3 6 13 20804549 10.1186/1756-6614-3-6
21. H Furuta Y Kondo S Nakahata M Hamasaki S Sakoda K Morishita 2010 NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma Biochem Biophys Res Commun. 391 1785 1791 20045673 10.1016/j.bbrc.2009.12.156 1:CAS:528:DC%2BC3cXhtVaqsLo%3D
22. A Lorentzen RH Lewinsky J Bornholdt LK Vogel C Mitchelmore 2011 Expression profile of the N-myc downstream regulated gene 2 (NDRG2) in human cancers with focus on breast cancer BMC Cancer. 11 14 21 21226903 10.1186/1471-2407-11-14 1:CAS:528:DC%2BC3MXhtVSitbw%3D
23. JE Price 1986 Clonogenicity and experimental metastatic potential of spontaneous mouse mammary neoplasms J Natl Cancer Inst. 77 529 535 3461213 1:STN:280:DyaL283ot12jtA%3D%3D
24. DM Peehl EJ Stanbridge 1981 Anchorage-independent growth of normal human fibroblasts Proc Natl Acad Sci USA. 78 3053 3057 6942414 10.1073/pnas.78.5.3053 1:STN:280:DyaL3M3kslChsw%3D%3D
25. DS Micalizzi SM Farabaugh HL Ford 2010 Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression J Mammary Gland Biol Neoplasia. 15 117 134 20490631 10.1007/s10911-010-9178-9
26. P Friedl D Gilmour 2009 Collective cell migration in morphogenesis, regeneration and cancer Nat Rev Mol Cell Biol. 10 445 457 19546857 10.1038/nrm2720 1:CAS:528:DC%2BD1MXnsFCmu7Y%3D
27. JR Testa A Bellacosa 2001 AKT plays a central role in tumorigenesis Proc Natl Acad Sci USA. 98 10983 10985 11572954 10.1073/pnas.211430998 1:CAS:528:DC%2BD3MXnt1yqsrY%3D
28. SJ Grille A Bellacosa J Upson, et al. 2003 The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines Cancer Res. 63 2172 2178 12727836 1:CAS:528:DC%2BD3sXjtlGmtrk%3D
29. A Bellacosa JR Testa R Moore L Larue 2004 A portrait of AKT kinases: human cancer and animal models depict a family with strong individualities Cancer Biol Ther. 3 268 275 15034304 10.4161/cbt.3.3.703 1:CAS:528: DC%2BD2cXmt1Cmsbo%3D
30. MC Hollander GM Blumenthal PA Dennis 2011 PTEN loss in the continuum of common cancers, rare syndromes and mouse models Nat Rev Cancer. 11 289 301 21430697 10.1038/nrc3037 1:CAS:528:DC%2BC3MXjs1CqsLc%3D
31. KA Waite Eng C Protean 2002 PTEN: form and function Am J Hum Genet. 70 829 844 11875759 10.1086/340026 1:CAS:528:DC%2BD38XivFClur8%3D
32. F Takahashi-Yanaga M Kahn 2010 Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clin Cancer Res. 16 3153 3162 20530697 10.1158/1078-0432.CCR-09-2943 1:CAS:528:DC%2BC3cXntlKru7o%3D
33. A Kim Y Yang MS Lee YD Yoo HG Lee JS Lim 2008 NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression Pigment Cell Melanoma Res. 21 653 664 19067970 10.1111/j.1755-148X.2008.00503.x 1:CAS:528:DC%2BD1MXmtleitw%3D%3D
34. MR Kim HK Choi KB Cho HS Kim KW Kang 2009 Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells Cancer Sci. 100 1834 1841 19681904 10.1111/j.1349-7006.2009.01260.x 1:CAS:528:DC%2BD1MXht12qs7jM
35. A Kim MJ Kim Y Yang JW Kim YI Yeom JS Lim 2009 Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells Carcinogenesis. 30 927 936 19336468 10.1093/carcin/bgp072 1:CAS:528:DC%2BD1MXntVWjtrk%3D